Eureka raises $21M in C round

Cancer company Eureka Therapeutics Inc. (Emeryville, Calif.) raised $21 million in an untranched series C round led by new investor Yuan Capital. Additional new investor Majuven and existing investors Acorn Campus Ventures, Suma Venture and Harbinger Venture Capital also participated. ...